Clinical trials
Screening clinical trials
Below are recruiting screening clinical trials, each written for real people, not researchers. We’re tracking 948 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05390567Recruiting
Mobile reminders to help women catch up on cancer screening
This study tests a mobile outreach effort to help women who are behind on recommended cervical cancer screening. It may help you learn when to get screened and connect you to care that may be easier to access.
Gainesville, FloridaAges 25–65 - NCT05298605Recruiting
Church-based program to help Korean women get breast screenings
This trial tests a faith-based (church-based) navigation program meant to help Korean women who have not had recent breast cancer screening get a mammogram. It may help by offering support and guidance through church and study staff.
Los Angeles, CaliforniaAges 45–80 - NCT05450094Enrolling by invitation
School program to meet children’s mental health needs
This study tests a school-based program designed to better support children’s mental health needs that are currently not being met. It focuses on students and the school team responsible for delivering the support.
Gainesville, FloridaAges 5–105 - NCT04750122RecruitingPhase 1/Phase 2
Drug-screening guided treatment before surgery for HER2 breast cancer
This trial tests a treatment plan that is chosen using drug-testing in a lab (to see which medicines may work best) before surgery. It is for people with early-stage HER2-positive breast cancer, aiming to improve outcomes by guiding the right treatment early.
Beijing, Beijing MunicipalityAges 18–75 - NCT05608694Recruiting
MRI screening for men at high risk of prostate cancer
This trial is testing whether MRI scans can help screen for signs of prostate cancer in men who have not been diagnosed yet but are at higher risk. It may help find concerning changes earlier so doctors can follow up sooner.
Chicago, IllinoisAges 18 years+ - NCT03851445RecruitingPhase 2/Phase 3
Lung cancer screening trial using tumor and blood test results
This trial helps sort people with previously treated lung cancer into the best next treatment options by using new tumor tissue (and sometimes blood) test results. It may help you get matched to therapies based on features like PD-L1 and other biomarkers.
Birmingham, AlabamaAges 18 years+ - NCT03322306Enrolling by invitation
Genetic testing study for inherited neurological conditions
This trial looks for genetic causes of inherited (in family) neurological diseases by using genetic screening. If you might have an inherited neurological condition, this study may help explain why symptoms happen and guide future care.
Hong Kong, ShatinAges 18–80 - NCT06529549Recruiting
Organoid drug test for advanced prostate cancer
This trial uses a lab test on a tiny sample of your tumor (called an organoid) to find which drug might work best for your advanced prostate cancer. It's for men whose cancer has stopped responding to hormone therapy and got worse after first treatment.
Guangzhou, GuangdongAges 18–75 - NCT07631624Recruiting
Blood test for lung cancer screening in smokers and former smokers
This study tests whether a simple blood test that detects smoking-related changes in DNA can help identify who should get lung cancer screening. Researchers want to see if this test is better at finding people at risk than current methods.
Antwerp, AntwerpenAges 50 years+ - NCT07623902Recruiting
Testing a Tongue Scan to Detect Colorectal Polyps
This study tests whether a new tongue-scanning tool called Gixam can help find advanced colorectal polyps in people with negative stool tests. If it works, it might offer a simpler screening option alongside colonoscopy.
Orlando, FloridaAges 45–84 - NCT07538050Recruiting
Testing a new, affordable HPV screening method
This study tests ScreenFire, a new low-cost test for HPV (a virus linked to cervical cancer) that you can do yourself at home. Researchers want to see if it works as well as standard tests and costs less.
San Salvador, OrienteAges 30–59 - NCT06074536Recruiting
Training doctors to share decisions in colorectal cancer screening
This study tests whether training doctors to better involve patients in decisions about colorectal cancer screening improves shared decision-making. If you are between 50 and 74 and due for screening, your GP might invite you to join.
Soisy-sous-MontmorencyAges 50–74 - NCT06439901Recruiting
Improving lung cancer screening in Ile-de-France
This trial tests a new way to screen for lung cancer in people at high risk due to smoking. If you are between 50 and 74, live in the Ile-de-France region, and have a long smoking history, you may be able to join and get a free screening.
BobignyAges 50–74 - NCT07682597Recruiting
Improving lung cancer screening in Nevada and Mississippi
This trial tests a new system (QUILS) to help state teams in Mississippi and Nevada improve lung cancer screening. You may join if you are part of a team working on this effort.
Greenville, MississippiAges 18–100 - NCT07639255Recruiting
Improving lung cancer screening in Kentucky
This study wants to see if a quality improvement program called QUILS can help healthcare workers find lung cancer earlier. It uses surveys, feedback, and interviews to improve how lung cancer screening is done.
Ashland, KentuckyAges 18–100 - NCT05006131Recruiting
Pancreatic cancer screening for people at higher risk
This study looks at how to screen the pancreas in people who are at increased risk for pancreatic cancer, using a set of risk guidelines. Screening may help find cancer (or early changes) sooner, when it may be easier to treat.
Boston, MassachusettsAges 18–90 - NCT07438080Recruiting
HPV self-screening vs. doctor screening for anal cancer risk
This trial compares two ways to screen for HPV, a virus linked to anal cancer. People living with HIV will either collect their own sample or have a doctor do it, then switch methods. The goal is to see which is more comfortable and accurate.
Saint-PaulAges 30–65 - NCT06931184Enrolling by invitation
Self-sampling for cervical cancer after missed screening
This trial offers a self-sampling test for cervical cancer screening. It is for women who missed their first screening and received a reminder letter. Instead of going to a clinic, you can collect a sample at home and send it in.
Tampere, PirkanmaaAges 30–65 - NCT06918106Recruiting
Alcohol screening and brief counseling for outpatients after war
This trial tests a short counseling session for outpatients who drink alcohol at risky levels. The goal is to help reduce alcohol use after experiencing war-related stress.
Shirē, TigrayAges 18 years+ - NCT07517692Enrolling by invitation
Improving shared decision-making for lung cancer screening
This study tests a new way to help patients and doctors discuss lung cancer screening together using text messages and shared decision-making tools. It may help you understand screening options better and make choices that fit your values.
Worcester, MassachusettsAges 50–77 - NCT07245862Recruiting
Family program for screen use conflicts
This study is for families who are dealing with conflicts about video games or screen use. It tests a program designed to help families work together and find a healthier balance.
LundAges 11–14 - NCT06801925Enrolling by invitation
Voice Chatbot for Depression Screening
This trial tests a voice chatbot that uses artificial intelligence to screen for depression. It aims to see if the chatbot is effective and easy to use.
LondonAges 18–65 - NCT06496295Enrolling by invitation
Testing a new speculum for cervical cancer screening
This trial tests a new kind of vaginal speculum (the tool used to look inside the vagina during a pelvic exam). It is for people who have never had this exam before, to see if it works well for cervical cancer screening.
Englewood, ColoradoAges 18–65 - NCT06934239RecruitingPhase 4
AI-assisted vs. standard mammograms for breast cancer screening
This trial compares standard mammograms with mammograms aided by artificial intelligence (AI) to see if AI helps find breast cancer more accurately and reduces unnecessary callbacks. If you're 18 or older and getting a routine screening mammogram at one of the six participating health systems, you may be eligible.
Los Angeles, CaliforniaAges 18 years+
Hear when a new Screening trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for screening?
- Yes. Clin2 currently lists 948 recruiting screening studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a screening trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a screening trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.